Abstract
Background
Oral anticoagulant therapy (OAT) with a vitamin K antagonist (VKA) is the choice of treatment for preventing thromboembolism in patients with mechanical heart valve prosthesis (MHP). The percentage of time in the therapeutic range (TTR%) expresses the OAT quality. We planned a case–control study in order to determine vitamin K1 plasmatic concentrations in MHP patients and to correlate these with TTR%.
Materials and Methods
Of 756 MHP patients receiving OAT, 125 patients (61 younger than 65 years, and 64 older than 65 years) and 120 healthy blood donors, matched for sex and age, were enrolled in the study. All subjects completed a living questionnaire regarding diet, and underwent blood collection. Vegetable and fruit intake was categorized as optimal or suboptimal, and the high-performance liquid chromatography method was used to determine vitamin K1 levels.
Results
Neither the patients nor controls had been taking vitamin supplements prior to the start of the study. The median vitamin K1 level was 290 pg/L in 72 controls with optimal intake, and 274 pg/L in 48 controls with suboptimal intake, while the median vitamin K1 level in MHP patients with optimal intake was 409 pg/L, significantly higher (p < 0.001) than the 133.5 pg/L in patients with suboptimal intake. Vitamin K1 concentration in MHP patients appears to be linked to an age-related threshold: in patients younger than 65 years of age, the median vitamin K1 level was 431 pg/L, significantly higher (p < 0.05) than the 290 pg/L in patients older than 65 years of age. No clear relation was found between vitamin K1 levels and TTR% (Pearson = 0.14). However, patients with vitamin K1 >160 pg/L showed a TTR% >60 %. Among patients younger than 65 years, subjects with vitamin K1 >160 pg/L showed a median TTR of 66 %, this being significantly higher (p < 0.001) than the 46 % level shown by patients with vitamin K1 <160 pg/L.
Conclusions
Vitamin K1 concentrations in MHP patients seem to be related to both diet and age.
Similar content being viewed by others
Change history
09 February 2019
Throughout the manuscript the units of plasma vitamin K1 concentration which previously read
09 February 2019
Throughout the manuscript the units of plasma vitamin K1 concentration which previously read
09 February 2019
Throughout the manuscript the units of plasma vitamin K1 concentration which previously read
References
Sun JC, Davidson MJ, Lamy A, Eikelboom JW. Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends. Lancet. 2009;374:565–76.
Eikelboom JW, Connoly SJ, Bruekmann M, Granger CB, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206–14.
Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulant: prospective evidence from observational and randomized protocol. Am J Med. 2004;116:651–6.
Herijgers P, Verhamme P. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for? Eur Heart J. 2007;28:2424–6.
Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonist: the Seventh ACCP Conference on Antithrombotic and Thrombolitic Therapy. Chest. 2004;126:204S–33S.
Koertke H, Zittermann A, Wagner O, Koerfer R. Self-management of oral anticoagulation therapy improves long-term survival in patients with mechanical heart valve replacement. Ann Thorac Surg. 2007;83(1):24–9.
Grzymala-Lubanski B, Labaf A, Englund E, Svensson PJ, Själander A. Mechanical heart valve prosthesis and warfarin: treatment quality and prognosis. Thromb Res. 2014;133:795–8.
Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005;165:1095–106.
Sconce E, Khan T, Mason J, Noble F, Wynne H, Kamali F. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost. 2005;93:872–5.
Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007;109:2419–23.
Rombouts EK, Rosendaal FR, van der Meer FJM. Influence of dietary vitamin K intake on sub-therapeutic oral anticoagulant therapy. Br J Haematol. 2010;149:598–605.
Gebius EPA, Rosendaal FR, van Meegen E, van der Meer FJM. Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose finding study. Haematologica. 2011;96:583–9.
de Assis MC, Rabelo ER, Avila CW, Polanczyk CA, Rohde LE. Improvedoralanticoagulationafter a dietary vitamin K-guided strategy. A randomized controlled trial. Circulation. 2009;120:1115–22.
Società Italiana di Nutrizione Umana (S.I.N.U.). Livelli di assunzione raccomandata di energia e nutrienti per la popolazione Italiana. LARN Revisione; 1996, pp 103–4.
Gentili A, Cafolla A, Gasperi T, Bellante S, Caretti F, Curini R, et al. Rapid, high performance method of vitamin K1, menaquinone-4 and vitamin K1 2,3-epoxide in human serum and plasma using liquid chromatography-hybrid quadropole linear ion trap mass spectrometry. J Chromatogr. 2014;1338:102–10.
Cafolla A, Melizzi R, Baldacci E, Pignoloni P, Dragoni F, Campanelli M, et al. “Zeus” a new oral anticoagulant therapy dosing algorithm: a cohort study. Thrombosis Res. 2011;128:325–30.
Rosendaal FR, Cannegieter SC, van der Meer FJM, Briët E. A method to determine the optimal intensity of an oral anticoagulant therapy. Thromb Haemost. 1993;69:236–9.
Booth SL, Centurelli MA. Vitamin K: a pratical guide to the dietary management of patients on warfarin. Nutr Rev. 1999;57:288–96.
Thane CW, Wang LY, Coward WA. Plasma phylloquinone (vitamin K1) concentration and its relationship to intake in British adults aged 19–64 years. Br J Nutr. 2006;96:1116–24.
Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C, Szulc P, Hodges S, et al. Beyond deficiency: potential benefits of increased intakes of vitamin k for bone and vascular health. Eur J Nutr. 2004;43:325–35.
Chouet J, Ferland G, Fèart C, Rolland Y, Presse N, Boucher K, et al. Dietary vitamin K intake is associated with cognition and behaviour among geriatric patients: the CLIP study. Nutrients. 2015;7:6739–50.
Acknowledgments
The authors are extremely grateful to Mr C.J.L. Hewlett (Durham University, UK) who revised the English form of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Arturo Cafolla, Alessandra Gentili, Clodomiro Cafolla, Virginia Perez, Erminia Baldacci, Daniela Pasqualetti, Bruna Demasiand, and Roberta Curini declare that they have no conflicts of interest.
Funding
No external funding was used in the conduct of this study.
Rights and permissions
About this article
Cite this article
Cafolla, A., Gentili, A., Cafolla, C. et al. Plasma Vitamin K1 Levels in Italian Patients Receiving Oral Anticoagulant Therapy for Mechanical Heart Prosthesis: A Case–Control Study. Am J Cardiovasc Drugs 16, 267–274 (2016). https://doi.org/10.1007/s40256-016-0169-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-016-0169-0